AAAAAA

   
Results: 1-21 |
Results: 21
Criteria for appropriate birth control
Authors: Westhoff, C
Citation: C. Westhoff, Criteria for appropriate birth control, GYNECOL END, 15, 2001, pp. 19-22
Screening for skin cancer - Recommendations and rationale
Authors: Berg, AO Allan, JD Frame, PS Homer, CJ Lieu, TA Mulrow, CD Orleans, CT Peipert, JF Pender, NJ Sox, HC Teutsch, SM Westhoff, C Woolf, SH
Citation: Ao. Berg et al., Screening for skin cancer - Recommendations and rationale, AM J PREV M, 20(3), 2001, pp. 44-46
Screening for bacterial vaginosis in pregnancy - Recommendations and rationale
Authors: Berg, AO Allan, JD Frame, PS Homer, CJ Lieu, TA Mulrow, CD Orleans, CT Peipert, JF Pender, NJ Sox, HC Teutsch, SM Westhoff, C Woolf, SH
Citation: Ao. Berg et al., Screening for bacterial vaginosis in pregnancy - Recommendations and rationale, AM J PREV M, 20(3), 2001, pp. 59-61
Screening for bacterial vaginosis in pregnancy
Authors: Guise, JM Mahon, SM Aickin, M Helfand, M Peipert, JF Westhoff, C
Citation: Jm. Guise et al., Screening for bacterial vaginosis in pregnancy, AM J PREV M, 20(3), 2001, pp. 62-72
Screening adults for lipid disorders - Recommendations and rationale
Authors: Berg, AO Allan, JD Frame, PS Homer, CJ Lieu, TA Mulrow, CD Orleans, CT Peipert, JF Pender, NJ Sox, HC Teutsch, SM Westhoff, C Woolf, SH
Citation: Ao. Berg et al., Screening adults for lipid disorders - Recommendations and rationale, AM J PREV M, 20(3), 2001, pp. 73-76
Screening for chlamydial infection - Recommendations and rationale
Authors: Berg, AO Allan, JD Frame, PS Homer, CJ Lieu, TA Mulrow, CD Orleans, CT Peipert, JF Pender, NJ Sox, HC Teutsch, SM Westhoff, C Woolf, SH
Citation: Ao. Berg et al., Screening for chlamydial infection - Recommendations and rationale, AM J PREV M, 20(3), 2001, pp. 90-94
Curettage after mifepristone-induced abortion: Frequency, timing, and indications - Reply
Authors: Westhoff, C Allen, R
Citation: C. Westhoff et R. Allen, Curettage after mifepristone-induced abortion: Frequency, timing, and indications - Reply, OBSTET GYN, 98(6), 2001, pp. 1149-1150
Curettage after mifepristone-induced abortion: Frequency, timing, and indications
Authors: Allen, RH Westhoff, C De Nonno, L Fielding, SL Schaff, EA
Citation: Rh. Allen et al., Curettage after mifepristone-induced abortion: Frequency, timing, and indications, OBSTET GYN, 98(1), 2001, pp. 101-106
Smoking and follicle numbers - Reply
Authors: Westhoff, C Murphy, P Heller, D
Citation: C. Westhoff et al., Smoking and follicle numbers - Reply, FERT STERIL, 75(6), 2001, pp. 1246-1246
Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion
Authors: Schaff, EA Fielding, SL Westhoff, C
Citation: Ea. Schaff et al., Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion, CONTRACEPT, 64(2), 2001, pp. 81-85
Diet and benign ovarian tumors (United States)
Authors: Britton, JA Westhoff, C Howe, G Gammon, MD
Citation: Ja. Britton et al., Diet and benign ovarian tumors (United States), CANC CAUSE, 11(5), 2000, pp. 389-401
Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion - A randomized trial
Authors: Schaff, EA Fielding, SL Westhoff, C Ellertson, C Eisinger, SH Stadalius, LS Fuller, L
Citation: Ea. Schaff et al., Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion - A randomized trial, J AM MED A, 284(15), 2000, pp. 1948-1953
Tubal sterilization - Safe and effective
Authors: Westhoff, C
Citation: C. Westhoff, Tubal sterilization - Safe and effective, N ENG J MED, 343(23), 2000, pp. 1724-1726
Predictors of ovarian follicle number
Authors: Westhoff, C Murphy, P Heller, D
Citation: C. Westhoff et al., Predictors of ovarian follicle number, FERT STERIL, 74(4), 2000, pp. 624-628
Tubal sterilization: focus on the US experience
Authors: Westhoff, C Davis, A
Citation: C. Westhoff et A. Davis, Tubal sterilization: focus on the US experience, FERT STERIL, 73(5), 2000, pp. 913-922
Timing of pain and bleeding after mifepristone-induced abortion
Authors: De Nonno, LJ Westhoff, C Fielding, S Schaff, E
Citation: Lj. De Nonno et al., Timing of pain and bleeding after mifepristone-induced abortion, CONTRACEPT, 62(6), 2000, pp. 305-309
Analgesia during at-home use of misoprostol as part of a medical abortion regimen
Authors: Westhoff, C Dasmahapatra, R Schaff, E
Citation: C. Westhoff et al., Analgesia during at-home use of misoprostol as part of a medical abortion regimen, CONTRACEPT, 62(6), 2000, pp. 311-314
Predictors of analgesia use during supervised medical abortion
Authors: Westhoff, C Dasmahapatra, R Winikoff, B Clarke, S
Citation: C. Westhoff et al., Predictors of analgesia use during supervised medical abortion, CONTRACEPT, 61(3), 2000, pp. 225-229
Lactose and benign ovarian tumours in a case-control study
Authors: Britton, JA Westhoff, C Howe, GR Gammon, MD
Citation: Ja. Britton et al., Lactose and benign ovarian tumours in a case-control study, BR J CANC, 83(11), 2000, pp. 1552-1555
Risk factors for hyperplasia-associated versus atrophy-associated endometrial carcinoma
Authors: Westhoff, C Heller, D Drosinos, S Tancer, L
Citation: C. Westhoff et al., Risk factors for hyperplasia-associated versus atrophy-associated endometrial carcinoma, AM J OBST G, 182(3), 2000, pp. 506-508
Oral contraceptives and benign ovarian tumors
Authors: Westhoff, C Britton, JA Gammon, MD Wright, T Kelsey, JL
Citation: C. Westhoff et al., Oral contraceptives and benign ovarian tumors, AM J EPIDEM, 152(3), 2000, pp. 242-246
Risultati: 1-21 |